STATE COLLEGE, Pa., Feb. 5 (UPI) -- A U.S. pilot study suggests a low dose of a pharmaceutical used to ease symptoms of drug addiction may also help sufferers of Crohn’s disease. Researchers at the Penn State College of Medicine suggest a low dose of the drug naltrexone may also bring relief to people with Crohn’s -- a chronic inflammatory disorder of the intestine that affects an estimated 500,000 people in the United States.>>> Discuss This Story
